TheEdgeResearch
Home / Stocks / QUCY

Quantum Cyber N.V. (QUCY)

NASDAQ Healthcare Medical - Diagnostics & Research
$1.30 ▼ -4.74%
Market Cap
$29.7M
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Beta
2.32
52-Wk Range
0.3-4.8799
CEO
David Elliot Lazar
Country
DE
Currency
USD

Quantum Cyber N.V. operates in the Medical - Diagnostics & Research industry of the Healthcare sector, headquartered in Mainz, DE. The stock last traded at $1.30, down 4.74% on the session, giving a market capitalisation of $29.7M. On trailing twelve-month figures it carries a trailing P/E of -3.03, a net margin of -2937.8%. Its beta of 2.32 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-3.03
Price / Sales
103.63
Price / Book
3.36
EV / EBITDA
-3.40
Gross margin
100.0%
Operating margin
-2723.5%
Net margin
-2937.8%
Return on equity
Debt / equity
0.03
Current ratio
2.11
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ Global Market
Employees
13
IPO date
2021-11-05
Headquarters
Mainz, DE
About Quantum Cyber N.V.

Quantum Cyber N.V. operates as a technology company focused on cybersecurity and quantum computing solutions. The company pursues acquisitions and partnerships in areas including post-quantum cryptography, zero-trust architecture, and national security technologies. It also develops platforms that integrate artificial intelligence (AI) and quantum computing technologies for autonomous control systems used in unmanned aerial, ground, and underwater vehicles, including drones, self-driving vehicles, and robotic fleets. Quantum Cyber N.V. was formerly known as Mainz Biomed N.V. and changed its name to Quantum Cyber N.V. in April 2026. The company is headquartered in Mainz, Germany.

More research on QUCY
QUCY technical analysis QUCY TheEdge Score Compare against peers
Open full interactive analysis & DCF →